DTIL

#3503
Precision BioSciences, Inc. Common Stock
4.20
+7.42%
Setor:
Base:
Moeda do lucro:
Faixa diária
4.20
4.20
Faixa anual
3.53
8.82
Mudança diária
+7.42%
Mudança mensal
+2.94%
Mudança em 6 meses
-16.67%
Mudança anual
-22.22%
Fechamento anterior
3.91
Open
4.20
Bid
Ask
Low
4.20
High
4.20
Volume
5
Open full chart

Financials

Overview Relatórios Statistics Dividends
Quarterly Annual
  • Market Capitalization 49.64 M
  • Employee 67
  • Founded 2006
  • CEO N/A
  • Website www.precisionbiosciences.com
  • Headquarter Delaware, United States
  • FIGI BBG008NSBPV3
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
3.66
Price to sales ratio
0.38
Dividends per share
—
Dividend yield %
—

Precision BioSciences Inc

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

Notícias